RNU6-1170P

Across TCGA pan-cancer cohorts, RNU6-1170P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU6-1170P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNU6-1170P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-1170P is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.

STAD, THCA, and LUSC are the cancer types where RNU6-1170P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-1170P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.593	.006	5	view →
THCA	All	II,III,IV	−0.402	<.001	5	view →
LUSC	All	II,III,IV	−0.167	.020	3	view →
LUAD	Male	All	+0.637	.026	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RNU6-1170P–STAD

Open the STAD breakdown →